Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Antitumor effects found for TG-4010 in prostate cancer patients

March 16, 2005

PSA-TRICOM vaccines show promise in the treatment of prostate cancer

March 15, 2005

Ceplene designated orphan drug in Europe for AML

March 14, 2005

Complete and partial responses in phase I/II study of MDX-010 for metastatic melanoma

March 14, 2005

Clinical evidence supports the use of TroVax in metastatic colorectal cancer

March 10, 2005

Pharmexa and BN ImmunoTherapeutics enter license agreement

March 9, 2005

First phase I data on the effects of GPI-0100 in prostate cancer

Feb. 28, 2005

Enrollment completed in phase II colorectal cancer study of HGS-ETR1

Feb. 25, 2005

Update on the antitumor effects of autologous Xcellerated T-cells in hematological malignancies

Feb. 24, 2005

New phase I/II study of AP-12009

Feb. 24, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...